plerixafor has been researched along with meperidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Adler, MW; Chen, X; Cowan, A; Doura, M; Eisenstein, TK; Geller, EB; Inan, S; Meissler, JJ; Rawls, SM; Tallarida, CS; Watson, MN | 1 |
1 review(s) available for plerixafor and meperidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for plerixafor and meperidine
| Article | Year |
|---|---|
Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats.
Topics: Analgesics, Opioid; Animals; Benzylamines; Cyclams; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Heterocyclic Compounds; Hyperalgesia; Male; Maraviroc; Meperidine; Oxycodone; Rats, Sprague-Dawley; Receptors, Chemokine | 2019 |